Circulation Journal
Online ISSN : 1347-4820
Print ISSN : 1346-9843
ISSN-L : 1346-9843
Letters to the Editor
How to Assess the Impact of Left Atrial Appendage Emptying Velocity on the Recurrence of Atrial Fibrillation After Catheter Ablation
Naoya KataokaTeruhiko Imamura
Author information
JOURNAL OPEN ACCESS FULL-TEXT HTML

2024 Volume 88 Issue 5 Pages 843-

Details

To the Editor:

Kim et al effectively illustrated that a diminished left atrial appendage emptying velocity (LAAV) stands as an autonomous predictor for the resurgence of atrial fibrillation (AF) post totally thoracoscopic ablation (TTA).1

The reduction in LAAV during AF due to the absence of atrial contraction is self-evident. Assessing LAAV during sinus rhythm is imperative.2 In the authors’ investigation, it appears that all patients exhibiting lower LAAV had persistent AF.1 Integrating this particular AF subtype into the multivariable analysis is advisable, considering its substantial impact on the recurrence rate. Enhancing LAAV levels can be accomplished through isoproterenol loading.3 Performing such a test on individuals with diminished LAAV could yield further valuable insights into identifying high-risk refractory patients.

In the authors’ institute,1 a routine post-procedural electrophysiologic study followed by cavo-tricuspid isthmus ablation was previously conducted. Presently, an electrophysiologic study, along with touch-up ablation, is exclusively administered to patients exhibiting atrial tachyarrhythmia refractory to epicardial ablation. This procedural variance might have influenced the recurrence rate. It is noteworthy that the presence of cavo-tricuspid isthmus ablation is anticipated to significantly impact the recurrence of atrial flutter.

Patients lacking left atrial appendage removal were excluded from their investigation.1 Some individuals with preserved LAAV might have experienced AF relapse, suggesting the potential involvement of the left atrial appendage as an AF trigger.4

Disclosure

None.

  • Naoya Kataoka, MD, PhD
  • Teruhiko Imamura, MD, PhD
  • Second Department of Internal Medicine, University of Toyama, Toyama, Japan

References
 
© 2024, THE JAPANESE CIRCULATION SOCIETY

This article is licensed under a Creative Commons [Attribution-NonCommercial-NoDerivatives 4.0 International] license.
https://creativecommons.org/licenses/by-nc-nd/4.0/
feedback
Top